Erica S Spatz1, Leslie A Curry1, Frederick A Masoudi1, Shengfan Zhou1, Kelly M Strait1, Cary P Gross1, Jeptha P Curtis1, Alexandra J Lansky1, Jose Augusto Soares Barreto-Filho1, Julianna F Lampropulos1, Hector Bueno1, Sarwat I Chaudhry1, Gail D'Onofrio1, Basmah Safdar1, Rachel P Dreyer1, Karthik Murugiah1, John A Spertus1, Harlan M Krumholz2. 1. From Section of Cardiovascular Medicine, Department of Internal Medicine (E.S.S., J.P.C., A.J.L., J.F.L., R.P.D., K.M., H.M.K.), Section of General Internal Medicine, Department of Internal Medicine (C.P.G., S.I.C.), Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine (L.A.C., C.P.G., H.M.K.), Yale Cardiovascular Research Group, Department of Internal Medicine (A.J.L.), and Department of Emergency Medicine (G.D., B.S.), Yale School of Medicine, New Haven, CT; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, CT (E.S.S., S.Z., K.M.S., J.P.C., J.A.S.B.-F., J.F.L., H.B., R.P.D., K.M., H.M.K.); Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (L.A.C., H.M.K.); Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora (F.A.M.); Division of Cardiology, Federal University of Sergipe, and the Clínica e Hospital São Lucas, Aracaju, Brazil (J.A.S.B.-F.); Department of Cardiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain (H.B.); and University of Kansas City-Missouri and Saint Luke's Mid America Heart Institute, Kansas City (J.A.S.). 2. From Section of Cardiovascular Medicine, Department of Internal Medicine (E.S.S., J.P.C., A.J.L., J.F.L., R.P.D., K.M., H.M.K.), Section of General Internal Medicine, Department of Internal Medicine (C.P.G., S.I.C.), Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine (L.A.C., C.P.G., H.M.K.), Yale Cardiovascular Research Group, Department of Internal Medicine (A.J.L.), and Department of Emergency Medicine (G.D., B.S.), Yale School of Medicine, New Haven, CT; Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, CT (E.S.S., S.Z., K.M.S., J.P.C., J.A.S.B.-F., J.F.L., H.B., R.P.D., K.M., H.M.K.); Department of Health Policy and Management, Yale School of Public Health, New Haven, CT (L.A.C., H.M.K.); Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora (F.A.M.); Division of Cardiology, Federal University of Sergipe, and the Clínica e Hospital São Lucas, Aracaju, Brazil (J.A.S.B.-F.); Department of Cardiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain (H.B.); and University of Kansas City-Missouri and Saint Luke's Mid America Heart Institute, Kansas City (J.A.S.). harlan.krumholz@yale.edu.
Abstract
BACKGROUND: Current classification schemes for acute myocardial infarction (AMI) may not accommodate the breadth of clinical phenotypes in young women. METHODS AND RESULTS: We developed a novel taxonomy among young adults (≤55 years) with AMI enrolled in the Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) study. We first classified a subset of patients (n=600) according to the Third Universal Definition of MI using a structured abstraction tool. There was heterogeneity within type 2 AMI, and 54 patients (9%; including 51 of 412 women) were unclassified. Using an inductive approach, we iteratively grouped patients with shared clinical characteristics, with the aims of developing a more inclusive taxonomy that could distinguish unique clinical phenotypes. The final VIRGO taxonomy classified 2802 study participants as follows: class 1, plaque-mediated culprit lesion (82.5% of women; 94.9% of men); class 2, obstructive coronary artery disease with supply-demand mismatch (2a: 1.4% women; 0.9% men) and without supply-demand mismatch (2b: 2.4% women; 1.1% men); class 3, nonobstructive coronary artery disease with supply-demand mismatch (3a: 4.3% women; 0.8% men) and without supply-demand mismatch (3b: 7.0% women; 1.9% men); class 4, other identifiable mechanism (spontaneous dissection, vasospasm, embolism; 1.5% women, 0.2% men); and class 5, undetermined classification (0.8% women, 0.2% men). CONCLUSIONS: Approximately 1 in 8 young women with AMI is unclassified by the Universal Definition of MI. We propose a more inclusive taxonomy that could serve as a framework for understanding biological disease mechanisms, therapeutic efficacy, and prognosis in this population.
BACKGROUND: Current classification schemes for acute myocardial infarction (AMI) may not accommodate the breadth of clinical phenotypes in young women. METHODS AND RESULTS: We developed a novel taxonomy among young adults (≤55 years) with AMI enrolled in the Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) study. We first classified a subset of patients (n=600) according to the Third Universal Definition of MI using a structured abstraction tool. There was heterogeneity within type 2 AMI, and 54 patients (9%; including 51 of 412 women) were unclassified. Using an inductive approach, we iteratively grouped patients with shared clinical characteristics, with the aims of developing a more inclusive taxonomy that could distinguish unique clinical phenotypes. The final VIRGO taxonomy classified 2802 study participants as follows: class 1, plaque-mediated culprit lesion (82.5% of women; 94.9% of men); class 2, obstructive coronary artery disease with supply-demand mismatch (2a: 1.4% women; 0.9% men) and without supply-demand mismatch (2b: 2.4% women; 1.1% men); class 3, nonobstructive coronary artery disease with supply-demand mismatch (3a: 4.3% women; 0.8% men) and without supply-demand mismatch (3b: 7.0% women; 1.9% men); class 4, other identifiable mechanism (spontaneous dissection, vasospasm, embolism; 1.5% women, 0.2% men); and class 5, undetermined classification (0.8% women, 0.2% men). CONCLUSIONS: Approximately 1 in 8 young women with AMI is unclassified by the Universal Definition of MI. We propose a more inclusive taxonomy that could serve as a framework for understanding biological disease mechanisms, therapeutic efficacy, and prognosis in this population.
Authors: Carl J Pepine; R David Anderson; Barry L Sharaf; Steven E Reis; Karen M Smith; Eileen M Handberg; B Delia Johnson; George Sopko; C Noel Bairey Merz Journal: J Am Coll Cardiol Date: 2010-06-22 Impact factor: 24.094
Authors: Harmony R Reynolds; Monvadi B Srichai; Sohah N Iqbal; James N Slater; G B John Mancini; Frederick Feit; Ivan Pena-Sing; Leon Axel; Michael J Attubato; Leonid Yatskar; Rebecca T Kalhorn; David A Wood; Iryna V Lobach; Judith S Hochman Journal: Circulation Date: 2011-09-06 Impact factor: 29.690
Authors: Judith H Lichtman; Nancy P Lorenze; Gail D'Onofrio; John A Spertus; Stacy T Lindau; Thomas M Morgan; Jeph Herrin; Héctor Bueno; Jennifer A Mattera; Paul M Ridker; Harlan M Krumholz Journal: Circ Cardiovasc Qual Outcomes Date: 2010-11
Authors: Rachel P Dreyer; Christopher Sciria; Erica S Spatz; Basmah Safdar; Gail D'Onofrio; Harlan M Krumholz Journal: Circ Cardiovasc Qual Outcomes Date: 2017-02-22
Authors: Nidaa Mikail; Alexia Rossi; Susan Bengs; Ahmed Haider; Barbara E Stähli; Angela Portmann; Alessio Imperiale; Valerie Treyer; Alexander Meisel; Aju P Pazhenkottil; Michael Messerli; Vera Regitz-Zagrosek; Philipp A Kaufmann; Ronny R Buechel; Cathérine Gebhard Journal: Eur J Nucl Med Mol Imaging Date: 2022-08-17 Impact factor: 10.057
Authors: Alexandre Abizaid; Carlos M Campos; Patrícia O Guimarães; José de Ribamar Costa; Breno A A Falcão; Fernanda Mangione; Adriano Caixeta; Pedro A Lemos; Fabio S de Brito; Ricardo Cavalcante; Cristiano Guedes Bezerra; Leandro Cortes; Henrique B Ribeiro; Francis R de Souza; Natassja Huemer; Renata M do Val; Bruno Caramelli; Daniela Calderaro; Felipe G Lima; Ludhmila A Hajjar; Roxana Mehran; Roberto Kalil Filho Journal: Catheter Cardiovasc Interv Date: 2021-04-27 Impact factor: 2.585
Authors: K H Humphries; M Izadnegahdar; T Sedlak; J Saw; N Johnston; K Schenck-Gustafsson; R U Shah; V Regitz-Zagrosek; J Grewal; V Vaccarino; J Wei; C N Bairey Merz Journal: Front Neuroendocrinol Date: 2017-04-18 Impact factor: 8.333